+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Antihistamines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4620282
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Akorn, Inc.
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • F. Hoffman-La Roche
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • MORE
Antihistamines Market - Growth, Future Prospects and Competitive Analysis, 2018-2026, the global antihistamines market will grow at a CAGR of 8.7% from 2018 to 2026.

Market Insights
The global antihistamines market is expected to grow at a CAGR of 8.7% during the forecast period from 2018 to 2026. Histamine is a key intermediary of instant hypersensitivity reactions acting locally and assisting vasodilation, smooth muscle contraction, high vascular permeability, inflammation, and edema. Antihistamines are representative of a class of drugs that inhibit the histamine type 1 (H1) receptors. H1 receptor is present on smooth muscle of bronchi, gastrointestinal tract, uterus, and large blood vessels. The major application of antihistamines has been observed in treatment of symptoms such as allergic conditions including itching, runny nose, nasal stuffiness, urticaria, teary eyes, dizziness, cough, and nausea. A few common side effects observed due to antihistamines treatment are sedation, impaired motor function, dry mouth & throat, dizziness, blurred vision, constipation and urinary retention. However, since a few decades modern drug development technologies have helped to reduce aforementioned side effects of antihistamines.

The two classes of antihistamines comprise first generation and second generation antihistamines. The first generation antihistamines comprises of drugs such as alimemazine, clemastine, chlorphenamine, hydroxyzine, cyproheptadine, ketotifen, promethazine and others. The drugs such as cetirizine, acrivastine, desloratadine, levocetirizine, fexofenadine, and loratadine. In 2017, second generation antihistamines segment was observed as the largest market as they are used as first line of action in diseases such as urticaria & common cold, and modern drug development technologies have assisted to enhance the activity of second generation antihistamines e.g.: Levocitirizine was developed from cetirizine to reduce dizziness caused by cetirizine. Thus, technological support is expected to develop the therapeutic effect of second generation antihistamines in the near future.

There are several applications of antihistamines such as allergic rhinitis, conjunctivitis, urticaria, atopic dermatitis, anaphylaxis and others (angioedema, pruritus, and others). Allergic rhinitis and urticaria together accounted more than 50% of the market share in year 2017 due to highest global prevalence of disease coupled with rising awareness and accessibility related to diagnosis and treatment of diseases. According to American Academy of Allergy Asthma & Immunology (AAAAI), globally allergic rhinitis affects around 10% to 30% of the population every year. Thus, the prevalence of diseases determine the demand for antihistamines in the market.
The global antihistamines market experiences huge competition due to the presence of several national and international market players. Since most of the drugs are generic and available over the counter which makes antihistamines market more competitive. Key players in the market include Bayer AG, Almirall S.A., Johnson & Johnson, AstraZeneca plc, Novartis AG, Pfizer, Inc., Sanofi SA, Boehringer Ingelheim GmbH, Merck & Co., Inc., Akorn, Inc., Teva Pharmaceutical Industries Ltd., and others.

Key Market Movements
  • Globally, the antihistamines market will significantly grow at a CAGR of 8.7% for the period from 2018 to 2026
  • First generation and second generation antihistamines are further sub-segmented including drugs such as Chlorphenamine, Alimemazine, Clemastine, Hydroxyzine, Cyproheptadine, Ketotifen, Acrivastine, Promethazine, Cetirizine, Fexofenadine, Desloratadine, Loratadine, and Levocetirizine
  • Second generation antihistamines was identified as the largest market and expected to retain its dominance throughout the forecast period from 2018 to 2026
  • Asia Pacific was identified as most promising region in the near future during the forecast period 2018 to 2026
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Akorn, Inc.
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • F. Hoffman-La Roche
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • MORE
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Antihistamines Market Portraiture
2.2. Global Antihistamines Market, by Antihistamines Type, 2017 (US$ Mn)
2.3. Global Antihistamines Market, by Application, 2017 (US$ Mn)
2.4. Global Antihistamines Market, by Geography, 2017 (US$ Mn)

Chapter 3. Antihistamines: Market Dynamics and Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Antihistamines Market, by Key Players, 2017

Chapter 4. Global Antihistamines Market, by Antihistamines Type, 2016–2026 (US$ Mn)
4.1. Overview
4.2. First Generation Antihistamines
4.2.1. Alimemazine
4.2.2. Chlorphenamine
4.2.3. Clemastine
4.2.4. Cyproheptadine
4.2.5. Hydroxyzine
4.2.6. Ketotifen
4.2.7. Promethazine
4.2.8. Others(Carbinoxamine, Dimenhydrinate, and others)
4.3. Second Generation Antihistamines
4.3.1. Acrivastine
4.3.2. Cetirizine
4.3.3. Desloratadine
4.3.4. Fexofenadine
4.3.5. Levocetirizine
4.3.6. Loratadine
4.4. Pipeline Analysis: Antihistamines Market
4.4.1. Phase III (Forecast till 2026)
4.4.2. Phase II (Tabular Representation)

Chapter 5. Global Antihistamines Market, by Application, 2016–2026 (US$ Mn)
5.1. Overview
5.2. Allergic Rhinitis
5.3. Conjunctivitis
5.4. Urticaria
5.5. Atopic Dermatitis
5.6. Anaphylaxis
5.7. Others (Angioedema, Pruritus, and others)

Chapter 6. Global Antihistamines Market, by Geography, 2016–2026 (US$ Mn)
6.1. Overview
6.2. North America Antihistamines Market, 2016–2026 (US$ Mn)
6.2.1. North America Antihistamines Market, by Antihistamines Type, 2016–2026 (US$ Mn)
6.2.2. North America Antihistamines Market, by Application, 2016–2026 (US$ Mn)
6.2.3. North America Antihistamines Market, by Country, 2016–2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Antihistamines Market, 2016–2026 (US$ Mn)
6.3.1. Europe Antihistamines Market, by Antihistamines Type, 2016–2026 (US$ Mn)
6.3.2. Europe Antihistamines Market, by Application, 2016–2026 (US$ Mn)
6.3.3. Europe Antihistamines Market, by Country/Region, 2016–2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Antihistamines Market, 2016–2026 (US$ Mn)
6.4.1. Asia Pacific Antihistamines Market, by Antihistamines Type, 2016–2026 (US$ Mn)
6.4.2. Asia Pacific Antihistamines Market, by Application, 2016–2026 (US$ Mn)
6.4.3. Asia Pacific Antihistamines Market, by Country/Region, 2016–2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America Antihistamines Market, 2016–2026 (US$ Mn)
6.5.1. Latin America Antihistamines Market, by Antihistamines Type, 2016–2026 (US$ Mn)
6.5.2. Latin America Antihistamines Market, by Application, 2016–2026 (US$ Mn)
6.5.3. Latin America Antihistamines Market, by Country/Region, 2016–2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Antihistamines Market, 2016–2026 (US$ Mn)
6.6.1. MEA Antihistamines Market, by Antihistamines Type, 2016–2026 (US$ Mn)
6.6.2. MEA Antihistamines Market, by Application, 2016–2026 (US$ Mn)
6.6.3. MEA Antihistamines Market, by Region, 2016–2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Profiles
7.1. Bayer AG
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Almirall S.A.
7.3. Johnson & Johnson
7.4. AstraZeneca plc
7.5. Novartis AG
7.6. Pfizer, Inc.
7.7. Sanofi SA
7.8. Boehringer Ingelheim GmbH
7.9. Merck & Co., Inc.
7.10. Akorn, Inc.
7.11. Teva Pharmaceutical Industries Ltd.
7.12. Celgene Corporation
7.13. F. Hoffman-La Roche

List of Figures:
Figure. 1 Antihistamines Market: Research Methodology
Figure. 2 Global Antihistamines Market, by Antihistamines Type, 2017 (Value %)
Figure. 3 Global Antihistamines Market, by Application Type, 2017 (Value %)
Figure. 4 Global Antihistamines Market, by Geography, 2017 (Value %)
Figure. 5 Attractive Investment Proposition, by Geography, 2017
Figure. 6 Global Alimemazine Market, 2016 – 2026 (US$ Mn)
Figure. 7 Global Chlorphenamine Market, 2016 – 2026 (US$ Mn)
Figure. 8 Global Clemastine Market, 2016 – 2026 (US$ Mn)
Figure. 9 Global Cyproheptadine Market, 2016 – 2026 (US$ Mn)
Figure. 10 Global Hydroxyzine Market, 2016 – 2026 (US$ Mn)
Figure. 11 Global Ketotifen Market, 2016 – 2026 (US$ Mn)
Figure. 12 Global Promethazine Market, 2016 – 2026 (US$ Mn)
Figure. 13 Global Others Market, 2016 – 2026 (US$ Mn)
Figure. 14 Global Acrivastine Market, 2016 – 2026 (US$ Mn)
Figure. 15 Global Cetirizine Market, 2016 – 2026 (US$ Mn)
Figure. 16 Global Desloratadine Market, 2016 – 2026 (US$ Mn)
Figure. 17 Global Fexofenadine Market, 2016 – 2026 (US$ Mn)
Figure. 18 Global Levocetirizine Market, 2016 – 2026 (US$ Mn)
Figure. 19 Global Antihistamines Market for Allergic Rhinitis Treatment, 2016 – 2026 (US$ Mn)
Figure. 20 Global Antihistamines Market for Conjunctivitis Treatment, 2016 – 2026 (US$ Mn)
Figure. 21 Global Antihistamines Market for Urticaria Treatment, 2016 – 2026 (US$ Mn)
Figure. 22 Global Antihistamines Market for Atopic Dermatitis Treatment, 2016 – 2026 (US$ Mn)
Figure. 23 Global Antihistamines Market for Anaphylaxis Treatment, 2016 – 2026 (US$ Mn)
Figure. 24 Global Antihistamines Market for Others Treatment, 2016 – 2026 (US$ Mn)
Figure. 25 U.S Antihistamines Market, 2016 – 2026 (US$ Mn)
Figure. 26 Canada Antihistamines Market, 2016 – 2026 (US$ Mn)
Figure. 27 U.K. Antihistamines Market, 2016 – 2026 (US$ Mn)
Figure. 28 Germany Antihistamines Market, 2016 – 2026 (US$ Mn)
Figure. 29 Rest of the Europe Antihistamines Market, 2016 – 2026 (US$ Mn)
Figure. 30 China Antihistamines Market, 2016 – 2026 (US$ Mn)
Figure. 31 Japan Antihistamines Market, 2016 – 2026 (US$ Mn)
Figure. 32 Rest of Asia Pacific Antihistamines Market, 2016 – 2026 (US$ Mn)
Figure. 33 Brazil Antihistamines Market, 2016 – 2026 (US$ Mn)
Figure. 34 Mexico Antihistamines Market, 2016 – 2026 (US$ Mn)
Figure. 35 Rest of Latin America Antihistamines Market, 2016 – 2026 (US$ Mn)
Figure. 36 GCC Antihistamines Market, 2016 – 2026 (US$ Mn)
Figure. 37 Rest of Middle East & Africa Antihistamines Market, 2016 – 2026 (US$ Mn)

List of Tables:
Table 1 Market Competition Assessment: Antihistamines, by Key Players
Table 2 Global Antihistamines Market, by Type of Antihistamines, 2016 - 2026 (US$ Mn)
Table 3 Global First Generation Antihistamines Market, by Drugs, 2016 - 2026 (US$ Mn)
Table 4 Global Second Generation Antihistamines Market, by Drugs, 2016 - 2026 (US$ Mn)
Table 5 Global Antihistamines Market, by Application, 2016 - 2026 (US$ Mn)
Table 6 Global Antihistamines Market, by Geography, 2016 – 2026 (US$ Mn)
Table 7 North America Antihistamines Market, by Type of Antihistamines, 2016 - 2026 (US$ Mn)
Table 8 North America Antihistamines Market, by Application, 2016 - 2026 (US$ Mn)
Table 9 North America Antihistamines Market, by Country, 2016 - 2026 (US$ Mn)
Table 10 Europe Antihistamines Market, by Type of Antihistamines, 2016 - 2026 (US$ Mn)
Table 11 Europe Antihistamines Market, by Application, 2016 - 2026 (US$ Mn)
Table 12 Europe Antihistamines Market, by Country/Region, 2016 - 2026 (US$ Mn)
Table 13 Asia Pacific Antihistamines Market, by Type of Antihistamines, 2016 - 2026 (US$ Mn)
Table 14 Asia Pacific Antihistamines Market, by Application, 2016 - 2026 (US$ Mn)
Table 15 Asia Pacific Antihistamines Market, by Country/Region, 2016 - 2026 (US$ Mn)
Table 16 Latin America Antihistamines Market, by Type of Antihistamines, 2016 - 2026 (US$ Mn)
Table 17 Latin America Antihistamines Market, by Application, 2016 - 2026 (US$ Mn)
Table 18 Latin America Antihistamines Market, by Country/Region, 2016 - 2026 (US$ Mn)
Table 19 Middle East & Africa Antihistamines Market, by Type of Antihistamines, 2016 - 2026 (US$ Mn)
Table 20 Middle East & Africa Antihistamines Market, by Application, 2016 - 2026 (US$ Mn)
Table 21 Middle East & Africa Antihistamines Market, by Region, 2016 - 2026 (US$ Mn)
Table 22 Bayer AG: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 23 Almirall S.A.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 24 Johnson & Johnson Limited: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 25 Astra Zeneca plc: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 26 Novartis AG: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 27 Pfizer, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 28 Sanofi SA: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 29 Boehringer Ingelheim GmbH: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 30 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 31 Akron, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 32 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 33 Celgene Corporation: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Table 34 F. Hoffman-La Roche: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bayer AG
  • Almirall S.A.
  • Johnson & Johnson
  • AstraZeneca plc
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi SA
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Akorn, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Celgene Corporation
  • F. Hoffman-La Roche
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4620282
Adroll
adroll